Have a personal or library account? Click to login
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM Cover

Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM

Radiology and Oncology
Volume 57 (2023): Issue 4 (December 2023)
By: Maria Ingenerf,  Homeira Karim,  Christoph Auernhammer,  Matthias Zacherl,  Vera Wenter,  Michael Winkelmann,  Jens Ricke,  Frank Berger and  Christine Schmid-Tannwald  
Open Access
|Nov 2023

Authors

Maria Ingenerf

Department of Radiology, University Hospital, LMU Munich, Munich, Germany

Homeira Karim

Department of Radiology, University Hospital, LMU Munich, Munich, Germany

Christoph Auernhammer

ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany
Department of Internal Medicine, University Hospital, LMU Munich, Munich, Germany

Matthias Zacherl

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

Vera Wenter

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

Michael Winkelmann

Department of Radiology, University Hospital, LMU Munich, Munich, Germany

Jens Ricke

Department of Radiology, University Hospital, LMU Munich, Munich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany

Frank Berger

Department of Radiology, University Hospital, LMU Munich, Munich, Germany

Christine Schmid-Tannwald

Christine.schmid-tannwald@med.uni-muenchen.de

Department of Radiology, University Hospital, LMU Munich, Munich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of Munich, Munich, Germany
DOI: https://doi.org/10.2478/raon-2023-0055 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 436 - 445
Submitted on: Jun 5, 2023
|
Accepted on: Sep 25, 2023
|
Published on: Nov 30, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prognosis,
positron emission tomography–computed tomography,
neuroendocrine tumors,
capecitabine/temozolomide
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2023 Maria Ingenerf, Homeira Karim, Christoph Auernhammer, Matthias Zacherl, Vera Wenter, Michael Winkelmann, Jens Ricke, Frank Berger, Christine Schmid-Tannwald, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 57 (2023): Issue 4 (December 2023)Next article